TOSLA and Geltor Collaborate to Launch Vegan Collagen Supplement for Skin Health Enhancement

TOSLA and Geltor Unveil a Revolutionary Vegan Collagen Supplement

In a groundbreaking step towards the future of beauty supplements, TOSLA, a leader in liquid nutraceutical innovation, has partnered with the biotechnology trailblazer Geltor to introduce the Signaling Collagen Shot. This innovative product not only emphasizes animal-free beauty but also focuses on promoting skin health, marking a significant advancement in ingestible beauty solutions.

The Product: Signaling Collagen Shot

The Signaling Collagen Shot is a ready-to-drink liquid supplement, powered by Geltor's PrimaColl®, a Type 21 signaling collagen polypeptide that is vegan and clinically validated. This product is designed to empower beauty-from-within concepts, specifically targeting brands that wish to expand into the ingestible category. The Signaling Collagen Shot offers a refreshing Cherry-Raspberry flavor while delivering a potent dose of 1g of PrimaColl in each 30 mL serving.

This new supplement is not just another addition to the beauty market; it represents a union of biodesigned peptides and proven scientific research, creating a product that is both effective and enjoyable to consume. Backed by significant clinical data, PrimaColl has been shown to improve key skin-signaling pathways that help enhance the skin's firmness, elasticity, and overall hydration.

Innovation and Efficacy

The collaboration between TOSLA and Geltor hinges on their complementary expertise in the realms of biotechnology and consumer health. Geltor's development of PrimaColl is pioneering, as it harnesses the power of biotechnology to produce a rare collagen type that is otherwise unattainable through traditional means. The FDA-cleared PrimaColl® is clinically tested, confirming its efficacy in skin improvements. In a double-blind study involving 170 women over a 12-week period, a remarkable 80-92% of participants noted enhanced skin texture and moisture levels when consuming 1-2.5g daily.

Sensory Experience through VELIOUS™ Flavor Technology

One of the standout features of the Signaling Collagen Shot is TOSLA's proprietary VELIOUS™ Flavor Technology. This technology ensures that the collagen supplement is not only effective but also enjoyable to integrate into daily routines. Uroš Gotar, the Chief Innovations Officer at TOSLA, emphasizes that for such supplements to yield positive results, they must become a part of daily rituals that consumers look forward to. Here lies the essence of TOSLA's vision—marrying wellness with pleasurable consumption.

Addressing Consumer Needs

A predominant challenge within the beauty supplement market has been ensuring consumer adherence. With the Signaling Collagen Shot's enjoyable flavor and seamless integration into daily life, TOSLA aims to transform how consumers engage with beauty supplements. Both companies are focused on bridging the gap between advanced biotechnology and accessible consumer products, ensuring that new scientific advancements reach everyday consumers.

Market Debut

The TOSLA x Geltor Signaling Collagen Shot is set to make its official debut at the upcoming Vitafood event in Barcelona from May 5-7, 2026, and will also be showcased at the NYSCC Suppliers' Day in New York City on May 19-20, 2026. Through these events, they aim to attract beauty brands looking to venture into the beauty-from-within segment while inspiring wellness brands to adopt this cutting-edge innovation.

In a nutshell, the partnership between TOSLA and Geltor is set to redefine the landscape of collagen supplementation by integrating advanced, vegan biotechnology with everyday health habits, enabling consumers to embrace a new era of beauty from within.